Verano Holdings (VRNO) Treasury Shares (2021 - 2026)
Verano Holdings' (VRNO) quarterly Treasury Shares came in at $2.6 million in Q1 2026, down 58.03% year-on-year from $6.2 million in Q1 2025, and down 7.87% on a QoQ basis from $2.8 million in Q4 2025.
Verano Holdings (VRNO) Treasury Shares (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Treasury Shares data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Treasury Shares fell 58.03% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 58.03% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 55.46% from the prior year.
- Treasury Shares for Q1 2026 stood at $2.6 million, down from $2.8 million in the prior quarter.
- Over the last five years, Treasury Shares for VRNO reached as high as $9.9 million in Q2 2023 and fell as low as $2.6 million in Q1 2026.
- Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $5.7 million in 2025.
- Across the five-year window, Treasury Shares soared 227.99% in 2023 and plunged 58.03% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $3.0 million in 2022, then surged by 195.59% to $8.8 million in 2023, then declined by 28.48% to $6.3 million in 2024, then sank by 55.46% to $2.8 million in 2025, then dropped by 7.87% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $2.6 million in Q1 2026, $2.8 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.66 Mn |
| Dec 31, 2023 | 8.81 Mn |
| Dec 31, 2023 | 8.81 Mn |